PRE-RECORDED 9-4-12 Tonight we will be discussing a little controversial subject Lithium. Read Dr. Goodman’s new article on her website at www.hddrugworks.org titled: NP03 Lithium: A Potential New Drug for HD NP03 is a new drug from Medesis Pharma that delivers lithium in a water and oil microemulsion that allows for much lower (15X lower) therapeutic dosing. Barring future problems, this drug may be on its way to study in people. Link:  http://bit.ly/R3BueM Lithium is so toxic, why revisit this drug reformulated in a lower (15X lower) dose? In May this year we talk about mouse models and the fact that therapeutic benefits may not carry over to human. Why try to formulate old drugs? What can you tell us about YAC mouse model? Are you familiar with Medesis Pharma? What is ISIS working on that will compliment this NP03 therapy? What about other mood stabilizers? Bottom line, work with your doctor and find the best drug solution for your patient

Ver todos los episodios